canrenone has been researched along with Liver Cirrhosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caligiuri, A; De Franco, RM; Failli, P; Geerts, A; Gentilini, A; Gentilini, P; Marra, F; Mazzetti, L; Meucci, M; Pinzani, M; Romanelli, RG; Rombouts, K; Vanasia, M | 1 |
Barletta, G; Del Bene, R; Gentilini, P; La Villa, G; Laffi, G; Mazzocchi, V; Pantaleo, P; Romanelli, RG; Vizzutti, F | 1 |
Juhos, E; Radó, JP; Sawinsky, I | 2 |
Gentilini, P | 1 |
Andriulli, A; Armanini, D; Arrigoni, A; Buzzetti, G; Gindro, T; Karbowiak, I | 1 |
2 trial(s) available for canrenone and Liver Cirrhosis
Article | Year |
---|---|
Cardiovascular effects of canrenone in patients with preascitic cirrhosis.
Topics: Aged; Ascites; Blood Pressure; Body Weight; Canrenone; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasma Volume; Sodium; Stroke Volume; Ventricular Function, Left | 2002 |
Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
Topics: Adult; Aged; Ascites; Canrenoic Acid; Canrenone; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pregnadienes; Random Allocation; Receptors, Androgen; Recurrence; Spironolactone; Testosterone; Time Factors | 1989 |
4 other study(ies) available for canrenone and Liver Cirrhosis
Article | Year |
---|---|
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
Topics: Aldosterone; Amiloride; Calcium; Canrenone; Cell Division; Cell Movement; Cells, Cultured; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Guanidines; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Liver; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Thrombin | 2003 |
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
Topics: Amiloride; Canrenone; Humans; Kidney Tubules; Liver Cirrhosis; Loop of Henle; Male; Middle Aged; Potassium; Pregnadienes; Pyrazines; Sodium; Spironolactone; Triamterene | 1976 |
Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
Topics: Amiloride; Ascites; Canrenone; Diuresis; Diuretics; Drug Synergism; Drug Therapy, Combination; Humans; Liver Cirrhosis; Natriuresis; Potassium; Spironolactone; Triamterene | 1976 |
Spironolactone and canrenoate: different antialdosteronic diuretic agents.
Topics: Ascites; Canrenoic Acid; Canrenone; Humans; Liver Cirrhosis; Recurrence; Spironolactone | 1991 |